Skip to main content
Top
Published in: International Urology and Nephrology 3/2019

01-03-2019 | Hyperparathyroidism | Nephrology - Original Paper

Peritoneal dialysis can alleviate the clinical course of hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism

Authors: Guang Yang, Yifei Ge, Xiaoming Zha, Huijuan Mao, Ningning Wang, Changying Xing

Published in: International Urology and Nephrology | Issue 3/2019

Login to get access

Abstract

Purpose

It is unclear whether clinical courses of hungry bone syndrome (HBS) after parathyroidectomy (PTX) in peritoneal dialysis (PD) and hemodialysis (HD) patients are different. The present study aimed to investigate the possible differences of postoperative hypocalcemia and hyperkalemia between PD and HD patients.

Methods

We performed retrospectively 29 PD patients as the PD group and 169 HD patients as the HD group undergoing successful total PTX with autotransplantation. Calcium supplement after surgery was recorded. Higher levels of serum potassium during and immediately after surgery were recorded as K+d0. K+d3 was recorded as peak pre-dialysis serum potassium level 3 days post-surgery.

Results

There were 157 (92.90%) patients in HD group and 22 (75.86%) patients in PD group suffered from HBS after surgery, with significant difference between the groups (P = 0.004). Patients in PD group had significantly shorter intravenous calcium supplement duration (P = 0.037) and significantly smaller intravenous calcium supplement dosage (P = 0.042) and total calcium supplement dosage during hospitalization (P = 0.012) than patients in HD group. The levels of serum K+d0 (P < 0.001) and K+d3 (P < 0.001) were both significantly lower in PD group than those in HD group. Peritoneal dialysis was one of the independent influencing factors with negative correlation for calcium supplement, serum K+d0 and serum K+d3.

Conclusions

Compared with HD patients, the clinical course of HBS after PTX in PD patients was alleviated. Efforts should be devoted to individual perioperative management for PD patients undergoing PTX.
Literature
1.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:1–59CrossRef Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:1–59CrossRef
2.
go back to reference Brasier AR, Nussbaum SR (1988) Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med 84:654–660CrossRefPubMed Brasier AR, Nussbaum SR (1988) Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med 84:654–660CrossRefPubMed
3.
go back to reference Ho LY, Wong PN, Sin HK et al (2017) Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. BMC Nephrol 18(1):12–21CrossRefPubMedPubMedCentral Ho LY, Wong PN, Sin HK et al (2017) Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. BMC Nephrol 18(1):12–21CrossRefPubMedPubMedCentral
4.
go back to reference Goldfarb M, Gondek SS, Lim SM et al (2012) Postoperative hungry bone syndrome in patients with secondary hyperparathyroidism of renal origin. World J Surg 36:1314–1319CrossRefPubMed Goldfarb M, Gondek SS, Lim SM et al (2012) Postoperative hungry bone syndrome in patients with secondary hyperparathyroidism of renal origin. World J Surg 36:1314–1319CrossRefPubMed
5.
go back to reference Latus J, Roesel M, Fritz P et al (2013) Incidence of and risk factors for hungry bone syndrome in 84 patients with secondary hyperparathyroidism. Int J Nephrol Renovasc Dis 8(6):131–137CrossRef Latus J, Roesel M, Fritz P et al (2013) Incidence of and risk factors for hungry bone syndrome in 84 patients with secondary hyperparathyroidism. Int J Nephrol Renovasc Dis 8(6):131–137CrossRef
6.
go back to reference Florescu MC, Islam KM, Plumb TJ et al (2014) Calcium supplementation after parathyroidectomy in dialysis and renal transplant patients. Int J Nephrol Renovasc Dis 14(7):183–190CrossRef Florescu MC, Islam KM, Plumb TJ et al (2014) Calcium supplementation after parathyroidectomy in dialysis and renal transplant patients. Int J Nephrol Renovasc Dis 14(7):183–190CrossRef
7.
go back to reference Tsai WC, Peng YS, Chiu YL et al (2015) Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism. Int Urol Nephrol 47(7):1203–1207CrossRefPubMed Tsai WC, Peng YS, Chiu YL et al (2015) Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism. Int Urol Nephrol 47(7):1203–1207CrossRefPubMed
8.
go back to reference Hayes JF, Gross GF, Schuman ES (1982) Surgical management of renal hyperparathyroidism in the dialysis patient. Am J Surg 143:569–571CrossRefPubMed Hayes JF, Gross GF, Schuman ES (1982) Surgical management of renal hyperparathyroidism in the dialysis patient. Am J Surg 143:569–571CrossRefPubMed
9.
go back to reference Cruz DN, Perazella MA (1997) Biochemical aberrations in a dialysis patient following parathyroidectomy. Am J Kidney Dis 29:759–762CrossRefPubMed Cruz DN, Perazella MA (1997) Biochemical aberrations in a dialysis patient following parathyroidectomy. Am J Kidney Dis 29:759–762CrossRefPubMed
10.
go back to reference Bajaj Y, Roberts S, Simon D et al (2011) Intra-operative hyperkalemia: a serious but under recognised complication of renal parathyroidectomy—a prospective study: how we do it. Clin Otolaryngol 36:69–72CrossRefPubMed Bajaj Y, Roberts S, Simon D et al (2011) Intra-operative hyperkalemia: a serious but under recognised complication of renal parathyroidectomy—a prospective study: how we do it. Clin Otolaryngol 36:69–72CrossRefPubMed
11.
go back to reference Yang YL, Lu HF, Chung KC et al (2015) Young age, male sex, and end-stage renal disease with secondary hyperparathyroidism as risk factors for intraoperative hyperkalemia during parathyroidectomy. J Clin Anesth 27:195–200CrossRefPubMed Yang YL, Lu HF, Chung KC et al (2015) Young age, male sex, and end-stage renal disease with secondary hyperparathyroidism as risk factors for intraoperative hyperkalemia during parathyroidectomy. J Clin Anesth 27:195–200CrossRefPubMed
12.
go back to reference Li S, Liu S, Chen Q et al (2018) Clinical predictor of postoperative hyperkalemia after parathyroidectomy in patients with hemodialysis. Int J Surg 53:1–4CrossRefPubMed Li S, Liu S, Chen Q et al (2018) Clinical predictor of postoperative hyperkalemia after parathyroidectomy in patients with hemodialysis. Int J Surg 53:1–4CrossRefPubMed
13.
go back to reference Hiramitsu T, Tominaga Y, Okada M et al (2015) A retrospective study of the impact of intraoperative intact parathyroid hormone monitoring during total parathyroidectomy for secondary hyperparathyroidism: STARD study. Medicine 94(29):e1213CrossRefPubMedPubMedCentral Hiramitsu T, Tominaga Y, Okada M et al (2015) A retrospective study of the impact of intraoperative intact parathyroid hormone monitoring during total parathyroidectomy for secondary hyperparathyroidism: STARD study. Medicine 94(29):e1213CrossRefPubMedPubMedCentral
14.
go back to reference Randolph GW (2013) Surgery of the thyroid and parathyroid glands. In: Tominaga Y (ed) Surgical management of secondary and tertialy hyperparathyroidism. Elsevier Saunders, Philadelphia, pp 639–647 Randolph GW (2013) Surgery of the thyroid and parathyroid glands. In: Tominaga Y (ed) Surgical management of secondary and tertialy hyperparathyroidism. Elsevier Saunders, Philadelphia, pp 639–647
15.
go back to reference Jofré R, López Gómez JM et al (2003) Parathyroidectomy: whom and when? Kidney Int Suppl 85:S97–S100CrossRef Jofré R, López Gómez JM et al (2003) Parathyroidectomy: whom and when? Kidney Int Suppl 85:S97–S100CrossRef
16.
go back to reference Edwards NC, Steeds RP, Chue CD et al (2012) The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease. Br J Clin Pharmacol 73(3):447–454CrossRefPubMed Edwards NC, Steeds RP, Chue CD et al (2012) The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease. Br J Clin Pharmacol 73(3):447–454CrossRefPubMed
17.
go back to reference Navarrete N (2018) Hyperkalemia in electrical burns: a retrospective study in Colombia. Burns 44(4):941–946CrossRefPubMed Navarrete N (2018) Hyperkalemia in electrical burns: a retrospective study in Colombia. Burns 44(4):941–946CrossRefPubMed
18.
go back to reference Kidney Disease: Improving Global Outcomes C-MWG (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 113:S1–S130 Kidney Disease: Improving Global Outcomes C-MWG (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 113:S1–S130
19.
20.
go back to reference Zhang LN, Yang G, Cheng C et al (2015) Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD. Osteoporos Int 26(1):395–405CrossRefPubMed Zhang LN, Yang G, Cheng C et al (2015) Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD. Osteoporos Int 26(1):395–405CrossRefPubMed
21.
go back to reference Yang G, Zhang B, Zha XM et al (2014) Total parathyroidectomy with autotransplantation for a rare disease derived from uremic secondary hyperparathyroidism, the uremic leontiasis ossea. Osteoporos Int 25(3):1115–1121CrossRefPubMed Yang G, Zhang B, Zha XM et al (2014) Total parathyroidectomy with autotransplantation for a rare disease derived from uremic secondary hyperparathyroidism, the uremic leontiasis ossea. Osteoporos Int 25(3):1115–1121CrossRefPubMed
22.
go back to reference Fukagawa M, Yokoyama K, Koiwa F, CKD-MBD Guideline Working Group; Japanese Society for Dialysis Therapy et al (2013) Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 17(3):247–288CrossRefPubMed Fukagawa M, Yokoyama K, Koiwa F, CKD-MBD Guideline Working Group; Japanese Society for Dialysis Therapy et al (2013) Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 17(3):247–288CrossRefPubMed
23.
25.
go back to reference Black DM, Bouxsein ML, Palermo L, PTH Once-Weekly Research (POWR) Group et al (2008) Randomized trial of once-weekly parathyroid hormone (1–84) on bone mineral density and remodeling. J Clin Endocrinol Metab 93(6):2166–2172CrossRefPubMedPubMedCentral Black DM, Bouxsein ML, Palermo L, PTH Once-Weekly Research (POWR) Group et al (2008) Randomized trial of once-weekly parathyroid hormone (1–84) on bone mineral density and remodeling. J Clin Endocrinol Metab 93(6):2166–2172CrossRefPubMedPubMedCentral
26.
go back to reference Silva I, Branco JC (2011) Rank/Rankl/opg: literature review. Acta Reumatol Port 36(3):209–218PubMed Silva I, Branco JC (2011) Rank/Rankl/opg: literature review. Acta Reumatol Port 36(3):209–218PubMed
27.
go back to reference Bauer D, Krege J, Lane N et al (2012) National bone health alliance bone turnover marker project: current practices and the need for US harmonization, standardization, and common reference ranges. Osteoporos Int 23(10):2425–2433CrossRefPubMedPubMedCentral Bauer D, Krege J, Lane N et al (2012) National bone health alliance bone turnover marker project: current practices and the need for US harmonization, standardization, and common reference ranges. Osteoporos Int 23(10):2425–2433CrossRefPubMedPubMedCentral
28.
go back to reference Lehmann G, Stein G, Hüller M et al (2005) Specific measurement of PTH (1–84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry. Kidney Int 68:1206–1214CrossRefPubMed Lehmann G, Stein G, Hüller M et al (2005) Specific measurement of PTH (1–84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry. Kidney Int 68:1206–1214CrossRefPubMed
29.
go back to reference Noordzij M, Cranenburg EM, Engelsman LF et al (2011) Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant 26(5):1662–1669CrossRefPubMed Noordzij M, Cranenburg EM, Engelsman LF et al (2011) Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant 26(5):1662–1669CrossRefPubMed
30.
go back to reference Khan AN, Bernardini J, Johnston JR et al (1996) Hypokalemia in peritoneal dialysis patients. Perit Dial Int 16:652PubMed Khan AN, Bernardini J, Johnston JR et al (1996) Hypokalemia in peritoneal dialysis patients. Perit Dial Int 16:652PubMed
31.
go back to reference Szeto CC, Chow KM, Kwan BC et al (2005) Hypokalemia in Chinese peritoneal dialysis patients: prevalence and prognostic implication. Am J Kidney Dis 46(1):128–135CrossRefPubMed Szeto CC, Chow KM, Kwan BC et al (2005) Hypokalemia in Chinese peritoneal dialysis patients: prevalence and prognostic implication. Am J Kidney Dis 46(1):128–135CrossRefPubMed
32.
go back to reference Chuang YW, Shu KH, Yu TM et al (2009) Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Nephrol Dial Transplant 24:1603–1608CrossRefPubMed Chuang YW, Shu KH, Yu TM et al (2009) Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Nephrol Dial Transplant 24:1603–1608CrossRefPubMed
Metadata
Title
Peritoneal dialysis can alleviate the clinical course of hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism
Authors
Guang Yang
Yifei Ge
Xiaoming Zha
Huijuan Mao
Ningning Wang
Changying Xing
Publication date
01-03-2019
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2019
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-019-02076-7

Other articles of this Issue 3/2019

International Urology and Nephrology 3/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.